The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: The Rancho Bernardo study

Journal of the American College of Cardiology

Volumn 59, Issue 19, 2012, Pages 1688-1696

  Laughlin, Gail A ^a   Cummins, Kevin M ^a   Wassel, Christina L ^a   Daniels, Lori B ^a,b   Ix, Joachim H ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

cardiovascular disease; diabetes mellitus; epidemiology; fetuin A; mortality

Indexed keywords

ESTROGEN; FETUIN A; LIPID; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK REDUCTION; SEX DIFFERENCE; VITAL SIGN;

ADULT; AGED; ALPHA-2-HS-GLYCOPROTEIN; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 84860450749     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.01.038     Document Type: Article

References (33)

1. J.H. Ix, G.M. Chertow, M.G. Shlipak, V.M. Brandenburg, M. Ketteler, M.A. Whooley Fetuin-A and kidney function in persons with coronary artery disease - data from the Heart and Soul Study Nephrol Dial Transplant 21 2006 2144 2151
2. M. Ketteler, G. Schlieper, J. Floege Calcification and cardiovascular health New insights into an old phenomenon Hypertension 47 2006 1027 1034
3. W. Jahnen-Dechent, A. Heiss, C. Schafer, M. Ketteler Fetuin-a regulation of calcified matrix metabolism Circ Res 108 2011 1494 1509
4. S.M. Moe, M. Reslerova, M. Ketteler Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD) Kidney Int 67 2005 2295 2304
5. A.Y. Wang, J. Woo, C.W. Lam Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients Nephrol Dial Transplant 20 2005 1676 1685
6. M. Ketteler, P. Bongartz, R. Westenfeld Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study Lancet 361 2003 827 833
7. P. Stenvinkel, K. Wang, A.R. Qureshi Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin Kidney Int 67 2005 2383 2392
8. M.M. Hermans, V. Brandenburg, M. Ketteler Association of serum fetuin-A levels with mortality in dialysis patients Kidney Int 72 2007 202 207
9. J.H. Ix, E. Barrett-Connor, C.L. Wassel The associations of fetuin-A with subclinical cardiovascular disease in community dwelling persons: the Rancho Bernardo study J Am Coll Cardiol 58 2011 2372 2379
10. J.H. Ix, G.M. Chertow, M.G. Shlipak, V.M. Brandenburg, M. Ketteler, M.A. Whooley Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study Circulation 115 2007 2533 2539
11. J.J. Kaden, J.O. Reinohl, B. Blesch Systemic and local levels of fetuin-A in calcific aortic valve stenosis Int J Mol Med 20 2007 193 197
12. P. Auberger, L. Falquerho, J.O. Contreres Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity Cell 58 1989 631 640
13. G. Rauth, O. Poschke, E. Fink The nucleotide and partial amino acid sequences of rat fetuin Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor Eur J Biochem 204 1992 523 529
14. J.H. Ix, M.G. Shlipak, V.M. Brandenburg, S. Ali, M. Ketteler, M.A. Whooley Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study Circulation 113 2006 1760 1767
15. K. Mori, M. Emoto, H. Yokoyama Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects Diabetes Care 29 2006 468
16. N. Stefan, A.M. Hennige, H. Staiger Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans Diabetes Care 29 2006 853 857
17. J.H. Ix, C.L. Wassel, A.M. Kanaya Fetuin-A and incident diabetes mellitus in older persons JAMA 300 2008 182 188
18. N. Stefan, A. Fritsche, C. Weikert Plasma fetuin-A levels and the risk of type 2 diabetes Diabetes 57 2008 2762 2767
19. S.T. Mathews, G.P. Singh, M. Ranalletta Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene Diabetes 51 2002 2450 2458
20. C. Schafer, A. Heiss, A. Schwarz The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification J Clin Invest 112 2003 357 366
21. Goustin AS, Abou-Samra AB. The "thrifty" gene encoding Ahsg/Fetuin-A meets the insulin receptor: insights into the mechanism of insulin resistance. Cell Signal;23:980-90.
22. The Hypertension Detection and Follow-up Program: Hypertension Detection and Follow-up Program Cooperative Group Prev Med 5 1976 207 215
23. G.A. Laughlin, E. Barrett-Connor, S. May Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones Int J Obes (Lond) 31 2007 457 465
24. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
25. A.S. Levey, T. Greene, J.W. Kusek, G.J. Beck A simplified equation to predict glomerular filtration rate from serum creatinine (abstr) J Am Soc Nephrol 11 2001 A0828
26. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease Am J Kidney Dis 49 Suppl 2 2007 S12 S154
27. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
28. M.J. Bradburn, T.G. Clark, S.B. Love, D.G. Altman Survival analysis Part III: multivariate data analysis - choosing a model and assessing its adequacy and fit Br J Cancer 89 2003 605 611
29. D. Collett Modelling Survival Data in Medical Research 1994 Chapman & Hall London, UK
30. M.W. Cleves An Introduction to Survival Analysis Using Stata: Revised Edition 2004 Stata Press College Station, TX
31. C. Weikert, N. Stefan, M.B. Schulze Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke Circulation 118 2008 2555 2562
32. R. Mehrotra, R. Westenfeld, P. Christenson Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification Kidney Int 67 2005 1070 1077
33. A.M. Hennige, H. Staiger, C. Wicke Fetuin-A induces cytokine expression and suppresses adiponectin production PLoS ONE 3 2008 e1765